 |
This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (March 2023) (Learn how and when to remove this message)
|
| Founder |
|
|---|---|
| Headquarters | London, UK
Bengaluru, India Abu Dhabi, UAE |
| Products |
|
Number of employees | 51-200 |
Ultrahuman is a Bengaluru based longevity and health-monitoring platform that designs, manufactures and sells the Ultrahuman Ring Air health tracker, Ultrahuman M1 Continuous glucose monitor, pre-release Ultrahuman Home health monitor and related blood testing services like Blood vision. Ultrahuman was incorporated in 2019 by second time entrepreneurs Mohit Kumar and Vatsal Singhal. Mohit and Vatsal also co-founded RoadRunnr in the year 2015. RoadRunnr later merged with Zomato[1] and eventually became Zomato Food delivery. Zomato went public at $15bn in market value in 2021.
Ultrahuman was founded by Mohit Kumar and Vatsal Singhal in 2019.[2]
Mohit Kumar, post his stint at Zomato, took a break to study martial arts at Tiger Muay Thai in Thailand. He initially observed athletes using biomarker data across streams such as glucose, HRV, blood markers etc and started designing a platform that the athletes could use to see all the data in one place. In January 2021, Ultrahuman launched its app at CES[3]inLos Angeles and Won the 'Best of CES award'. In June 2021, it launched a continuous glucose monitor called Ultrahuman M1 (formerly known as Ultrahuman Cyborg).[4]
In April 2022, Ultrahuman acquired LazyCo - a wearables IOT company.[5] LazyCo built hardware products like an AI-powered smart ring designed to predict and automate daily tasks.[6][7][8]
In June 2023, Ultrahuman won the Red Dot award at Berlin for its flagship Ultrahuman Ring Air. Ultrahuman has also raised 3 rounds of investments in the year 2020, 2022 and 2024 totalling up to $65 million. Ultrahuman claims to be EBITDA profitable and has declared its IPO plans for 2026.
Ultrahuman conducted a multi-armed observational study[9] which included 105 non-diabetic and pre-diabetic individuals. It aimed to show metabolic health as a continuous spectrum between non-diabetic and diabetic individuals. The clinical trial showed a correlation between its health score 'Metabolic score' and inflammation in the body. The trial also included blood markers and gut-microbiome index markers.
The research got published in Nature ,[9] and generated controversy due to the inclusion of non-diabetic individuals in the trial.[citation needed]
Ultrahuman claims to have a global patent on the ring design and the charger along with 150 odd trademarks. Notably, it is fighting a patent litigation with the Finnish wearables company Oura ring.[citation needed]
Ultrahuman has raised $65 million across three rounds of investments.
Ultrahuman raised $7.5 mn in Seed round from Nexus Venture partners and Blume ventures.[10]
In their Series A round,[11] Ultrahuman raised $17.5M in funding from Alpha Wave Incubation (AWI),[12][13] Steadview Capital, Nexus Venture Partners, Blume Ventures and iSeed fund.
Balaji Srinivasan (ex-Coinbase), Nithin Kamath (founder of Zerodha via Rainmatter), Kunal Shah (founder of CRED), Preethi Kasireddy (ex-a16z), Akshay BD (founding team Uber India), RazorPay founders and Tanmay Bhat (celebrity content creator and investor) along with several others, have invested in Ultrahuman.[14][15][16]
Ultrahuman launched its first design and manufacturing facility in Bengaluru, India called 'UltraFactory' in the year 2022. The factory claimed to have the capacity to manufacture 10,000 devices monthly. Ultrahuman announced in 2024 that it has extended the UltraFactory to grow by 7x in capacity.[17]
